{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:08:56Z","timestamp":1759565336479},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1245\/s10434-015-4534-z","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T11:20:50Z","timestamp":1427282450000},"page":"4217-4223","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection"],"prefix":"10.1245","volume":"22","author":[{"given":"Roberto","family":"Angioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Capriglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Di Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Plotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"4534_CR1","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(11)70154-X","volume":"47","author":"JA Ledermann","year":"2011","unstructured":"Ledermann JA, Raja FA. Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer. 2011;47:S104\u201315.","journal-title":"Eur J Cancer."},{"key":"4534_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2407-14-22","volume":"14","author":"Van Laar de","year":"2014","unstructured":"Van de Laar, et al. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study. BMC Cancer. 2014;14:22.","journal-title":"BMC Cancer."},{"key":"4534_CR3","doi-asserted-by":"crossref","unstructured":"Al Rawahi T, Lopes AD, Bristow RE. Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2013;28:2.","DOI":"10.1002\/14651858.CD008765.pub3"},{"key":"4534_CR4","doi-asserted-by":"crossref","unstructured":"Plotti F, Scaletta G, Aloisi A, Luvero D, Capriglione S, Miranda A, Montera R, De Cicco Nardone C, Terranova C, Angioli R. Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy. Ann Surg Oncol. 2015 Jan 13.","DOI":"10.1245\/s10434-014-4263-8"},{"key":"4534_CR5","doi-asserted-by":"crossref","unstructured":"Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynecol Obstet. 2003;83:(1 Suppl):135\u201366.","DOI":"10.1016\/S0020-7292(03)90118-4"},{"issue":"12","key":"4534_CR6","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, et al. Surgery in recurrent ovarian cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)DESKTOP OVAR Trial. Ann Surg Oncol. 2006;13(12):1702-10.","journal-title":"Ann Surg Oncol."},{"key":"4534_CR7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, Bois AD, Hahmann M, et al. Surgery in recurrent ovarian cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol. 2006;13:1702\u201310.","journal-title":"Ann Surg Oncol."},{"key":"4534_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","volume":"19","author":"WJ Tian","year":"2012","unstructured":"Tian WJ, Chi DS, Sehouli J, Trope CG, Jiang R, Ayhan A, et al. A risk model for second- ary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Ann Surg Oncol. 2012;19:597\u2013604.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"4534_CR9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s13277-012-0471-7","volume":"33","author":"F Plotti","year":"2012","unstructured":"Plotti F, Capriglione S, Terranova C, Montera R, Aloisi A, Damiani P, Muzii L, Scaletta G, Benedetti-Panici P, Angioli R. Does HE4 have a role as biomarker in the recurrence of ovarian cancer? Tumour Biol. 2012;33(6):2117-23. doi: 10.1007\/s13277-012-0471-7 . Epub 2012 Aug 9. PubMed PMID: 22875782.","journal-title":"Tumour Biol."},{"issue":"7","key":"4534_CR10","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","volume":"35","author":"R Angioli","year":"2014","unstructured":"Angioli R, Capriglione S, Aloisi A, Guzzo F, Luvero D, Miranda A, Damiani P, Montera R, Terranova C, Plotti F. Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? Tumour Biol. 2014;35(7):7009-15.","journal-title":"Tumour Biol."},{"key":"4534_CR11","doi-asserted-by":"crossref","unstructured":"Angioli R, Plotti F, Capriglione S, Aloisi A, Montera R, Luvero D, Miranda A, Caf\u00e0 EV, Damiani P, Benedetti-Panici P. Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol. 2012 Dec 7.","DOI":"10.1016\/j.ygyno.2012.11.040"},{"issue":"2","key":"4534_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47.","journal-title":"Eur J Cancer."},{"key":"4534_CR13","doi-asserted-by":"crossref","unstructured":"Angioli R, Plotti F, Capriglione S, Montera R, Damiani P, Ricciardi R, Aloisi A, Luvero D, Caf\u00e0 EV, Dugo N, Angelucci M, Benedetti-Panici P. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. Tumour Biol. 2012 Nov 20.","DOI":"10.1007\/s13277-012-0583-0"},{"key":"4534_CR14","doi-asserted-by":"crossref","unstructured":"Angioli R, Miranda A, Aloisi A, Montera R, Capriglione S, De Cicco Nardone C, Terranova C, Plotti F. A critical review on HE4 performance in endometrial cancer: where are we now? Tumour Biol. 2013 Sep 26.","DOI":"10.1007\/s13277-013-1190-4"},{"issue":"20","key":"4534_CR15","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-13-1376","volume":"19","author":"R Angioli","year":"2013","unstructured":"Angioli R, Capriglione S, Aloisi A, Luvero D, Caf\u00e0 EV, Dugo N, Montera R, De Cicco Nardone C, Terranova C, Plotti F. REM (risk of endometrial malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy. Clin Cancer Res. 2013;19(20):5733-9.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"4534_CR16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.fertnstert.2005.01.111","volume":"84","author":"L Muzii","year":"2005","unstructured":"Muzii L, Bellati F, Manci N, Zullo MA, Angioli R, Panici PB. Ringer\u2019s lactate solution remains in the peritoneal cavity after laparoscopy longer than expected. Fertil Steril. 2005;84(1):148\u201353.","journal-title":"Fertil Steril."},{"key":"4534_CR17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373\u20139.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"4534_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2014.09.017","volume":"136","author":"CK Lee","year":"2015","unstructured":"Lee CK. Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CAPLYPSO trial. Gynecol Oncol. 2015;136(1):18\u201324.","journal-title":"Gynecol Oncol."},{"key":"4534_CR19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2010.31.2124","volume":"29","author":"JK Chan","year":"2011","unstructured":"Chan JK, Sherman AE, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011;29:832\u20138.","journal-title":"J Clin Oncol."},{"key":"4534_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejogrb.2014.11.015","volume":"184","author":"F Plotti","year":"2015","unstructured":"Plotti F, Capriglione S, Miranda A, Scaletta G, Aloisi A, Luvero D, Ricciardi R, Terranova C, De Cicco Nardone C, Angioli R. The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2015;184:19\u201323.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"4534_CR21","doi-asserted-by":"crossref","unstructured":"Fanfani F, Monterossi G, Fagotti A, Gallotta V, Costantini B, Vizzielli G, Petrillo M, Carbone MV, Scambia G. Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol. 2014.","DOI":"10.1245\/s10434-014-4011-0"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4534-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4534-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4534-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T07:47:18Z","timestamp":1566460038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4534-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4534-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]}}}